EPISODE · Dec 30, 2024 · 29 MIN
Novel Antiviral Targets Viral Methyltransferases
from Heliox: Where Evidence Meets Empathy 🇨🇦 · host by SC Zoomers
Send us Fan MailIn this engaging episode of the Deep Dive, two passionate science enthusiasts explore groundbreaking research into a new class of antiviral drugs that target viral methyltransferases. Moving beyond familiar treatments like Paxlovid, they discuss how these novel antivirals could potentially combat a wide range of viruses, from COVID-19 to Ebola and dengue. The hosts break down complex concepts with warmth and clarity, explaining how viruses use methyltransferases as a "disguise" to evade our immune system and how targeting these enzymes could revolutionize our approach to treating viral infections. They thoughtfully explore not just the science, but also the broader implications for global health, pandemic preparedness, and the future of medicine. Join them for an illuminating conversation that makes cutting-edge research accessible while capturing the excitement and promise of this potential medical breakthrough.Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferase https://www.nature.com/articles/s41586-024-08320-0A Novel Class of Antivirals Targets Enzymes Common to Many RNA Viruses https://www.technologynetworks.com/biopharma/news/a-novel-class-of-antivirals-targets-enzymes-common-to-many-rna-viruses-394223This is Heliox: Where Evidence Meets EmpathyIndependent, moderated, timely, deep, gentle, clinical, global, and community conversations about things that matter. Breathe Easy, we go deep and lightly surface the big ideas. Support the showDisclosure: This podcast uses AI-generated synthetic voices for a material portion of the audio content, in line with Apple Podcasts guidelines. We make rigorous science accessible, accurate, and unforgettable.Produced by Michelle Bruecker and Scott Bleackley, it features reviews of emerging research and ideas from leading thinkers, curated under our creative direction with AI assistance for voice, imagery, and composition. Systemic voices and illustrative images of people are representative tools, not depictions of specific individuals.We dive deep into peer-reviewed research, pre-prints, and major scientific works—then bring them to life through the stories of the researchers themselves. Complex ideas become clear. Obscure discoveries become conversation starters. And you walk away understanding not just what scientists discovered, but why it matters and how they got there.Independent, moderated, timely, deep, gentle, clinical, global, and community conversations about things that matter. Breathe Easy, we go deep and lightly surface the big ideas.Spoken word, short and sweet, with rhythm and a catchy beat.http://tinyurl.com/stonefolksongs
Embed this episode
What this episode covers
Send us Fan Mail In this engaging episode of the Deep Dive, two passionate science enthusiasts explore groundbreaking research into a new class of antiviral drugs that target viral methyltransferases. Moving beyond familiar treatments like Paxlovid, they discuss how these novel antivirals could potentially combat a wide range of viruses, from COVID-19 to Ebola and dengue. The hosts break down complex concepts with warmth and clarity, explaining how viruses use methyltransferases as a "disguis...
Ready to play
Novel Antiviral Targets Viral Methyltransferases
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.